Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07LQX
|
|||
Former ID |
DNC010397
|
|||
Drug Name |
2-fluorophenyl 4-(undecyloxy)phenylcarbamate
|
|||
Synonyms |
CHEMBL609024; 2-fluorophenyl 4-(undecyloxy)phenylcarbamate
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C24H32FNO3
|
|||
Canonical SMILES |
CCCCCCCCCCCOC1=CC=C(C=C1)NC(=O)OC2=CC=CC=C2F
|
|||
InChI |
1S/C24H32FNO3/c1-2-3-4-5-6-7-8-9-12-19-28-21-17-15-20(16-18-21)26-24(27)29-23-14-11-10-13-22(23)25/h10-11,13-18H,2-9,12,19H2,1H3,(H,26,27)
|
|||
InChIKey |
PDDXKUNCGFODGC-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
BioCyc | Anandamide degradation | |||
KEGG Pathway | Retrograde endocannabinoid signaling | |||
Panther Pathway | Anandamide degradation |
References | Top | |||
---|---|---|---|---|
REF 1 | Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.